What does Be The Match BioTherapies invest in?
Be The Match BioTherapies invests most often at Series A and Series B (100% of the rounds on record), in sectors such as Messaging and Mobile.

Last cheque observed Jan 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietInvestment firm
2 rounds on record
Mostly Series A and Series B: 100% of its rounds
Every round we can evidence, newest first2 appearances
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Be The Match BioTherapies invests most often at Series A and Series B (100% of the rounds on record), in sectors such as Messaging and Mobile.
2 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2018.
Its most recent investments on record: Tmunity (Series A, Jan 2018) and Magenta Therpeutics (Series B, May 2017).
The median round it joins is $75M.
No investments in the last 12 months; the latest was in Jan 2018.
Be The Match BioTherapies is an investment firm.
From 2 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it